Search Results 341-350 of 15263 for Polycystic kidney disease
Understanding what underlies autosomal dominant polycystic kidney disease and searching for new therapies; Biomarkers of heart and kidney diseases; Glomerular ...
The purpose of this multi-center event-driven study in participants with anemia associated with chronic kidney disease (CKD) to evaluate the safety and efficacy ...
D., is the director of the Mayo Clinic Translational Polycystic Kidney Disease (PKD) Center, supported by the National Institutes of Health (NIH) and the ...
The purpose of this study is to evaluate the safety of tolvaptan in pediatric subjects with autosomal recessive polycystic kidney disease (ARPKD). Participation ...
Learn about kidney failure symptoms, tests, diagnosis and treatment options, including medicine, dialysis and kidney transplant.
Factors that drive progressive kidney damage in chronic kidney disease; Reasons for increased risk of heart and blood vessel (cardiovascular) complications in ...
Baseline chronic kidney disease (CKD) is an important risk factor for cardiovascular illness, hospitalization and mortality — and these risks are greater at ...
The retrospective review of 1,981 patients who were treated for chronic kidney disease at Mayo Clinic between 1997 and 2000 found that over a 10.2-year follow- ...
The Genetics, Epigenetics and Metabolomics Core at Mayo Clinic offers six main PKD services for research and tools for polycystic kidney disease.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.